Stocks and Investing Stocks and Investing
Mon, January 7, 2019
[ 12:00 AM ] - United States, WOPRAI
Matthew McClintock Upgraded (AAP) to Buy and Increased Target to $205 on, Jan 7th, 2019
[ 12:00 AM ] - United States, WOPRAI
Carlo Santarelli Maintained (VAC) at Hold with Decreased Target to $93 on, Jan 7th, 2019
[ 12:00 AM ] - United States, WOPRAI
Matthew Boss Downgraded (URBN) to Hold and Decreased Target to $38 on, Jan 7th, 2019
[ 12:00 AM ] - United States, WOPRAI
Meta Marshall Maintained (BAND) at Hold with Increased Target to $46 on, Jan 7th, 2019
[ 12:00 AM ] - United States, WOPRAI
Anthony Pettinari Maintained (BERY) at Strong Buy with Increased Target to $60 on, Jan 7th, 2019
Fri, January 4, 2019
[ 12:00 AM ] - United States, WOPRAI
David Leiker Downgraded (ALV) to Sell and Decreased Target to $64 on, Jan 4th, 2019
[ 12:00 AM ] - United States, WOPRAI
Mark Schappel Upgraded (AZPN) to Strong Buy on, Jan 4th, 2019
[ 12:00 AM ] - United States, WOPRAI
David Leiker Downgraded (VC) to Hold on, Jan 4th, 2019
[ 12:00 AM ] - United States, WOPRAI
Walter Pritchard Maintained (AAPL) at Strong Buy with Decreased Target to $43 on, Jan 4th, 2019
[ 12:00 AM ] - United States, WOPRAI
Alexander Blostein Upgraded (ARES) to Strong Buy and Held Target at $23 on, Jan 4th, 2019
[ 12:00 AM ] - United States, WOPRAI
Matthew Harrison Initiated (ARGX) at Buy and Held Target at $140 on, Jan 4th, 2019
[ 12:00 AM ] - United States, WOPRAI
David Leiker Downgraded (ADNT) to Sell and Decreased Target to $14 on, Jan 4th, 2019
[ 12:00 AM ] - United States, WOPRAI
Mitch Steves Downgraded (ADI) to Hold on, Jan 4th, 2019
[ 12:00 AM ] - United States, WOPRAI
Steve Beuchaw Maintained (ALGN) at Hold with Decreased Target to $210 on, Jan 4th, 2019
[ 12:00 AM ] - United States, WOPRAI
Alexander Blostein Upgraded (CBOE) to Strong Buy and Held Target at $120 on, Jan 4th, 2019
[ 12:00 AM ] - United States, WOPRAI
Michael Cyprys Maintained (BX) at Buy with Decreased Target to $36 on, Jan 4th, 2019
[ 12:00 AM ] - United States, WOPRAI
Andrew Wittmann Maintained (UNF) at Buy with Decreased Target to $152 on, Jan 4th, 2019
[ 12:00 AM ] - United States, WOPRAI
Scott Gruber Maintained (WHD) at Strong Buy with Decreased Target to $41 on, Jan 4th, 2019
[ 12:00 AM ] - United States, WOPRAI
Scott Schrier Maintained (WMS) at Hold with Decreased Target to $27 on, Jan 4th, 2019
[ 12:00 AM ] - United States, WOPRAI
Michael Cyprys Maintained (BLK) at Buy with Decreased Target to $489 on, Jan 4th, 2019
[ 12:00 AM ] - United States, WOPRAI
Alexander Blostein Downgraded (TROW) to Hold and Held Target at $93 on, Jan 4th, 2019
[ 12:00 AM ] - United States, WOPRAI
Michael Cyprys Maintained (TROW) at Hold with Decreased Target to $98 on, Jan 4th, 2019
[ 12:00 AM ] - United States, WOPRAI
Vivek Arya Downgraded (TXN) to Hold on, Jan 4th, 2019
[ 12:00 AM ] - United States, WOPRAI
Anthony Pettinari Maintained (SUM) at Strong Buy with Decreased Target to $18 on, Jan 4th, 2019
[ 12:00 AM ] - United States, WOPRAI
John Lovallo Upgraded (AWI) to Strong Buy and Held Target at $75 on, Jan 4th, 2019
[ 12:00 AM ] - United States, WOPRAI
Kristen Stewart Downgraded (AVNS) to Sell and Decreased Target to $36 on, Jan 4th, 2019
[ 12:00 AM ] - United States, WOPRAI
Christopher Growe Maintained (SMPL) at Strong Buy with Increased Target to $22 on, Jan 4th, 2019
[ 12:00 AM ] - United States, WOPRAI
Heath Terry Downgraded (SNAP) to Hold and Decreased Target to $6 on, Jan 4th, 2019
[ 12:00 AM ] - United States, WOPRAI
Jack Atkins Upgraded (SNDR) to Buy on, Jan 4th, 2019
[ 12:00 AM ] - United States, WOPRAI
Robyn Karnauskas Maintained (VRTX) at Strong Buy with Decreased Target to $205 on, Jan 4th, 2019

Robyn Karnauskas Maintained (VRTX) at Strong Buy with Decreased Target to $205 on, Jan 4th, 2019


Published on 2024-10-26 11:31:18 - WOPRAI, Robyn Karnauskas
  Print publication without navigation


Robyn Karnauskas of Citigroup, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Strong Buy with Decreased Target from $206 to $205 on, Jan 4th, 2019.

Robyn has made no other calls on VRTX in the last 4 months.



There are 4 other peers that have a rating on VRTX. Out of the 4 peers that are also analyzing VRTX, 1 agrees with Robyn's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Christopher Raymond of "Raymond James" Downgraded from Buy to Hold on, Wednesday, January 2nd, 2019


These are the ratings of the 3 analyists that currently disagree with Robyn

  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $210 on, Wednesday, December 19th, 2018
  • Andrew Fein of "HC Wainwright & Co." Upgraded from Hold to Strong Buy and Held Target at $220 on, Friday, October 26th, 2018
  • Do Kim of "BMO Capital" Maintained at Buy with Decreased Target to $192 on, Thursday, October 25th, 2018

Contributing Sources